SUSIANTO, INDRA ADI (2026) The inhibition of deep peritoneal endometriosis by Andrographolide through macrophage M1 activity in an endometriosis mice model. Veterinarni Medicina, 70 (2). pp. 62-72. ISSN 1805-9392

Preview

Text The inhibition of deep peritoneal belum ada ST.pdf Download (2MB) | Preview

Abstract

This study aims to demonstrate that Andrographolide, an herbal immunostimulant, can influence M1 macrophages to inhibit inflammation, including the growth of endometriosis caused by inflammation. This study evaluates the effects of Andrographolide on suppressing endometriosis through M1 macrophage activity. This post-test-only experimental study involved 42 female Balb/C mice, which were divided into six groups: Group N, KN (endometriosis without therapy), and KP (endometriosis + dienogest), P1 (endometriosis with 0.05 mg/kg), P2 (endometriosis + 0.1 mg/kg Andrographolide), and P3 (endometriosis + 0.2 mg/kg Andrographolide). Perito-neal fluid was aspirated, and the peritoneum was cut and stretched to observe the extent of the endometriosis. This study compared the formation of ectopic endometrial lesions and analysed the M1/M2 ratio in each group that received standard therapy versus Andrographolide therapy. The results from peritoneal fluid flow cytometry indicated that M1 was more dominant than M2 compared with KP. The levels of M2 in the P2 and P3 groups were also significantly lower than in the KN group. This study demonstrated that Andrographolide may enhance the regulation of M1 macrophage differentiation, acting as a precursor to endometriosis growth by suppressing M2 phenotypes that promote the condition.

Actions (login required)

View Item